This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by McCrady, C. W. Articles by Carchman, R. A. Search for Related Content PubMed PubMed Citation Articles by McCrady, C. W. Articles by Carchman, R. A.

Alteration of Human Lymphokine-activated Killer Cell Activity by Manipulation of Protein Kinase C and Cytosolic Ca²⁺¹

Departments of Pharmacology and Toxicology [C. W. M., R. A. C.] and of Anatomy [A. J. G., R. E. M.], Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298, and Artificial Liver Support System Lab [F. L.], First University Hospital, Chongqing University of Medical Sciences, Chongqing Sichuan, People's Republic of China

We have examined the effects of protein kinase C (PK-C) stimulation and cytosolic Ca²⁺ elevation on the in vitro induction of non-histocompatibility-restricted tumoricidal activity from human peripheral blood lymphocytes. The tumor cytolytic activity, as well as the number of cells recovered from interleukin 2 (IL-2)-stimulated cultures, was enhanced by the addition of the PK-C stimulator, phorbol dibutyrate (PDBu), but not non-PK-C-activating phorbol ester analogues while the Ca²⁺ ionophore, ionomycin, did not significantly alter development of IL-2-induced tumor cytolytic activity nor enhance cell yield. Neither PDBu nor ionomycin, alone or in combination, induced tumoricidal activity. The addition of both PDBu and ionomycin to recombinant interleukin 2 (rIL-2)-exposed cultures produced a strong mitogenic response and high cell yield, although Daudi cell killing measured at Day 5 was completely abolished. This abrogation of lymphokine-activated killer cell activity was seen as early as 24 h following exposure to PDBu and ionomycin, reaching 50% following 2 days of exposure. When lymphocytes mitogenically expanded by primary exposure to PDBu and ionomycin and then washed free of these agents were further cultured with rIL-2 alone, proliferation continued, and substantial cytolytic activity for Daudi cells was induced. The development of this postexpansion cytotoxic activity was not dependent on the addition of exogenous rIL-2 during the primary cultures. Fractionation of cells into large granular lymphocytes and small T-lymphocytes indicated that only the large granular lymphocytes proliferate in response to rIL-2 alone. Both large granular lymphocytes and small T-lymphocytes proliferate in response to the addition of PDBu and ionomycin, and both populations of cells developed tumor cytolytic activity following removal of PDBu and ionomycin and subsequent culture in rIL-2. These data suggest that PK-C and Ca²⁺ signals play key roles in the regulation and/or proliferation of tumor cytotoxic lymphocytes or their precursors and that manipulation of those signals can be utilized to produce substantially more tumoricidal activity from lymphocyte populations than can be achieved with rIL-2 alone.

¹ This investigation was supported by the National Institute of Neurological and Communicative Disorders and Stroke Grant NS 21313, the National Institute for Environmental Health Sciences Grant ES 03572, and the National Institute on Drug Abuse Grant DA 04502-01.

² To whom requests for reprints should be addressed, at Department of Pharmacology/Toxicology, Virginia Commonwealth University, Box 613, MCV Station, Richmond, VA 23298.

Received 6/10/87. Revised 10/19/87. Accepted 10/26/87.